Chemicals

1-Methylpiperazine

We are 1-Methylpiperazine CAS:109-01-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Methylpiperazine

CAS.NO:109-01-3

Synonyms:1-Methylpiperazine

methylpiperazine

4-Methylpiperazine

N-METHYL-PIPERAZINE

N-Methylpiperazine

Physical and Chemical Properties:

Density 0.9±0.1 g/cm3

Boiling Point 138.0±8.0 °C at 760 mmHg

Melting Point -6 °C

Molecular Formula C5H12N2

Molecular Weight 100.162

Flash Point 42.2±0.0 °C

Vapour density 3.5 (vs air)

Vapour Pressure 6.9±0.3 mmHg at 25°C

Index of Refraction 1.442

Specification:

Appearance:Colorless to light yellow liquid

Assay:≥99.5%

Moisture:≤0.5%

Piperazine:≤0.1%

N,N'-Dimethylpiperazine:≤0.1%

Packing:200 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Netupitant(CAS:290297-26-6)、Rifampicin(CAS:13292-46-1)、Trifluoperazine(CAS:117-89-5)、Clozapine(CAS:5786-21-0)、Sildenafil(CAS:139755-83-2)、Zopiclone(CAS:43200-80-2) and Ofloxacin(CAS:82419-36-1).

1-Methylpiperazine

Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.4-fluorobencilamina CAS:140-75-0 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”N-Tert-Butoxycarbonyl-4-(4-Toluenesulfonyloxymethyl)Piperidine CAS:166815-96-9 This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.4-nitrophenol CAS:100-02-7 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.

Product Name
Acetoacetic acid-(5-chloro-2-methoxy-anilide)	View Details
n-butyl isocyanate	View Details
(Z)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)acrylate	View Details